Exact Mass: 649.2049684000001

Exact Mass Matches: 649.2049684000001

Found 32 metabolites which its exact mass value is equals to given mass value 649.2049684000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pyranodelphinin A

11-hydroxy-3-methyl-6-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-7-(3,4,5-trihydroxyphenyl)-2λ⁴,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1,3,5(13),6,9,11-hexaen-2-ylium

C30H33O16 (649.1768518)


Pyranodelphinin A is found in fruits. Pyranodelphinin A is a constituent of the seeds of Ribes nigrum (blackcurrant) Constituent of the seeds of Ribes nigrum (blackcurrant). Pyranodelphinin A is found in fruits.

   

2-(4-(Bis(carboxymethyl)amino)-3-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)phenyl)-1H-indole-6-carboxylic acid

2-(4-(Bis(carboxymethyl)amino)-3-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)phenyl)-1H-indole-6-carboxylic acid

C32H31N3O12 (649.1907646)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D064449 - Sequestering Agents > D002614 - Chelating Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

Malvidin 3-caffeoyl-glucoside

3-{[(2S,3R,4S,5S,6R)-6-({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-(3-ethenyl-5-methoxy-4-methylphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium

C34H33O13 (649.1921068)


Malvidin 3-caffeoyl-glucoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Malvidin 3-caffeoyl-glucoside can be found in common grape, which makes malvidin 3-caffeoyl-glucoside a potential biomarker for the consumption of this food product.

   

Dihydro,di-Ac-Ravidomycin

Dihydro,di-Ac-Ravidomycin

C35H39NO11 (649.2522984)


   
   

Raloxifene 6-glucuronide

Raloxifene-6-glucuronide

C34H35NO10S (649.198157)


   

Raloxifene-4-glucuronide

Raloxifene-4-glucuronide

C34H35NO10S (649.198157)


   

TCYTY

Thr Cys Tyr Thr Tyr

C29H39N5O10S (649.2417514)


   

Pyranodelphinin A

11-hydroxy-7-methyl-4-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-3-(3,4,5-trihydroxyphenyl)-2$l^{4},8-dioxatricyclo[7.3.1.0^{5,13}]trideca-1(12),2,4,6,9(13),10-hexaen-2-ylium

C30H33O16 (649.1768518)


   

UNII:73033I28Y6

Mosapride citrate dihydrate

C27H37ClFN3O12 (649.2049684000001)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents

   

5-DMT-Bz-rC

5-DMT-Bz-rC

C37H35N3O8 (649.2424030000001)


5'-O-DMT-Bz-Rc is a modified nucleoside and can be used to synthesize DNA or RNA.

   

bis(trimethylsilyl)azanide,thulium(3+)

bis(trimethylsilyl)azanide,thulium(3+)

C18H54N3Si6Tm (649.2275434)


   

Sibofimloc

Antibiotic-202

C35H39NO11 (649.2522984)


C254 - Anti-Infective Agent > C258 - Antibiotic

   

Glycine, N-[2-[[(9H-fluoren-9-ylMethoxy)carbonyl]aMino]ethyl]-N-[[6-[[(phenylMethoxy)carbonyl]aMino]-9H-purin-9-yl]acetyl]-

Glycine, N-[2-[[(9H-fluoren-9-ylMethoxy)carbonyl]aMino]ethyl]-N-[[6-[[(phenylMethoxy)carbonyl]aMino]-9H-purin-9-yl]acetyl]-

C34H31N7O7 (649.2284855999999)


   

PF 3084014 hydrobromide

PF 3084014 hydrobromide

C27H43Br2F2N5O (649.1802211999999)


C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

[7-Methyl-3-(3,4,5-trihydroxyphenyl)-4-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-ylidene]oxidanium

[7-Methyl-3-(3,4,5-trihydroxyphenyl)-4-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-ylidene]oxidanium

C30H33O16+ (649.1768518)


   

Malvidin 3-caffeoyl-glucoside

Malvidin 3-caffeoyl-glucoside

C34H33O13+ (649.1921068)


   
   

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp

C23H39NO20 (649.2065334)


alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp in which the anomeric configuration of the reducing-end glucose is beta.

   
   

alpha-Neu5Gc-(2->6)-beta-Gal-(1->4)-Glc

alpha-Neu5Gc-(2->6)-beta-Gal-(1->4)-Glc

C23H39NO20 (649.2065334)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide

C32H38F3N3O6S (649.2433284000001)


   
   

NeuGc(a2-3)[Gal(b1-4)]Gal

NeuGc(a2-3)[Gal(b1-4)]Gal

C23H39NO20 (649.2065334)


   

3,5-dideoxy-5-glycolamido-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose

3,5-dideoxy-5-glycolamido-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose

C23H39NO20 (649.2065334)


   

NeuGc(a2-6)Gal(b1-4)b-Glc

NeuGc(a2-6)Gal(b1-4)b-Glc

C23H39NO20 (649.2065334)


   

NeuGc(a2-3)[Gal(b1-4)]a-Gal

NeuGc(a2-3)[Gal(b1-4)]a-Gal

C23H39NO20 (649.2065334)


   

NeuGc(a2-3)[Gal(b1-4)]b-Gal

NeuGc(a2-3)[Gal(b1-4)]b-Gal

C23H39NO20 (649.2065334)


   

Indo 1

2-(4-(Bis(carboxymethyl)amino)-3-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)phenyl)-1H-indole-6-carboxylic acid

C32H31N3O12 (649.1907646)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D064449 - Sequestering Agents > D002614 - Chelating Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp

C23H39NO20 (649.2065334)


An amino trisaccharide consisting of an N-glycoloylneuraminosyl residue linked alpha(2->3) to a lactose moiety.

   

FASN-IN-4 (tosylate)

FASN-IN-4 (tosylate)

C33H35N3O7S2 (649.191632)


FASN-IN-4 tosylate is a potent inhibitor of fatty acid synthase (FASN) with an IC50 of 10 nM (WO2012064642A1, compound 29)[1]. FASN-IN-4 tosylate also inhibits SARS-CoV-2 with an EC50 of 18.6?nM[2].